FEDERAL COURT OF AUSTRALIA
Unilever Australia Ltd v Revlon Australia Pty Ltd (No 3) [2014] FCA 1005
Citation: Unilever Australia Ltd v Revlon Australia Pty Ltd (No 3) [2014] FCA 1005 Parties: UNILEVER AUSTRALIA LIMITED (ACN 004 050 828) v REVLON AUSTRALIA PTY LTD (ACN 095 360 731) File number: NSD 508 of 2014 Judge: GLEESON J Date of judgment: 16 September 2014 Catchwords: PRACTICE AND PROCEDURE – confidentiality orders – whether confidential exhibits to respondent’s affidavit may be disclosed to applicant’s in house counsel – whether exhibits may be disclosed to other persons for purposes of the proceedings – where parties are trade rivals – where documents would be subject to usual implied undertaking Legislation: Federal Court of Australia Act 1976 (Cth) s 50 Cases cited: Autodata Ltd v Boyce’s Automotive Data Pty Ltd [2007] FCA 1517
ICAP Australia Pty Ltd v Moebes [2010] NSWSC 738
Cyclopet Pty Ltd v Australian Nuclear Science and Technology Org [2012] FCA 1326
Forty Two International Pty Ltd v Barnes (No 4) [2012] FCA 1059Date of hearing: 11 September 2014 Place: Sydney Division: GENERAL DIVISION Category: Catchwords Number of paragraphs: 21 Counsel for the Applicant: Mr Richard Cobden SC Solicitor for the Applicant: Baker & McKenzie Counsel for the Respondent: Mr Michael Hall with Ms Edwina Whitby Solicitor for the Respondent: King + Wood Mallesons
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 508 of 2014
BETWEEN: UNILEVER AUSTRALIA LIMITED (ACN 004 050 828)
ApplicantAND: REVLON AUSTRALIA PTY LTD (ACN 095 360 731)
Respondent
JUDGE:
GLEESON J
DATE OF ORDER:
16 SEPTEMBER 2014
WHERE MADE:
SYDNEY
THE COURT ORDERS THAT:
1.Despite any confidentiality undertaking concerning documents including exhibits MDT-27, MDT-28 (as redacted), MDT-30 and MDT-32 referred to in the third affidavit of Dr Michael David Traudt sworn 3 September 2014, each of those documents may be disclosed to any person for the purpose of these proceedings.
Note:Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 508 of 2014
BETWEEN: UNILEVER AUSTRALIA LIMITED (ACN 004 050 828)
ApplicantAND: REVLON AUSTRALIA PTY LTD (ACN 095 360 731)
Respondent
JUDGE:
GLEESON J
DATE:
16 SEPTEMBER 2014
PLACE:
SYDNEY
REASONS FOR JUDGMENT
The applicant/cross-respondent (“Unilever”) applies for an order that, in substance, authorises the use of four documents received from the respondent/cross-claimant (“Revlon”) pursuant to confidentiality undertakings. The terms of the undertakings are:
1.Subject to any Order of or authorisation by the Court, or without the written consent of the Respondent through its solicitors to the contrary, and further subject to paragraph 2 below:
(a)I will keep the documents and information confidential at all times and will not disclose them (either in whole or in part) either directly or indirectly to any person including the parties to these proceedings, their in-house counsel, any company within the Unilever group of companies or the respective employees and agents of…
Keep reading for free
Create a free CaseChat account to read Unilever Australia Ltd v Revlon Australia Pty Ltd (No 3) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2014] FCA 1005
- Decision Date
CaseChat Overview and Summary
The court considered the evidence provided by both parties and examined the documents in question. The court noted that the documents contained information about Revlon's testing processes and methods, but also contained results of the clinical evaluations. The court found that the degree to which the differences between the information in the disputed documents and the previously disclosed document were commercially sensitive was not obvious. The court concluded that the information claimed to be confidential was not particularly sensitive, and that its disclosure would not confer any material advantage upon Unilever or cause Revlon any material disadvantage.
The court held that the four documents should be disclosed to any person for the purpose of these proceedings, subject to the usual implied undertaking. The court found that the opinions expressed by Dr Traudt upon the basis of the four documents were central to one aspect of the dispute between the parties, namely the reasonableness of Revlon’s representations as to the efficacy of the Mitchum Clinical Strength “Oxygen Roll-On”. The court did not accept Revlon's contention that it would be reasonable for Unilever to be restricted to addressing this evidence through independent experts without the benefit of instructions concerning the document, or the opportunity to obtain evidence in reply from one or more Unilever employees.
Orders
Orders of the court
1. Despite any confidentiality undertaking concerning documents including exhibits MDT-27, MDT-28 (as redacted), MDT-30 and MDT-32 referred to in the third affidavit of Dr Michael David Traudt sworn 3 September 2014, each of those documents may be disclosed to any person for the purpose of these proceedings.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
As to the need to access the documents, Unilever made the following submissions:a.The conclusions drawn by Dr Traudt on the basis of the material in the four documents are “absolutely central” to the reasonable belief case in respect of which his affidavit is put forward;b.Unilever wishes to show the documents to Mr Friedrich, Ms Carvell, and to one or more other potential witnesses who are employees of Unilever, and any others who might assist Unilever in the review of the documents;c.As to Ms Carvell, she has given an affidavit in the proceedings dealing with comparative product testing of the same nature as the tests which are the subject of exhibits MDT-28 and 30 (without any claims for confidentiality by Unilever other than as to product formulation);d.Unilever needs to take the steps in (b) above in order to prepare its evidence in reply. Consideration I have examined the four disputed documents, as well as MDT-10. That examination revealed the following:a.the information in the documents is not solely concerned with Revlon’s testing processes and methods. For example, MDT-27, MDT-28 and MDT-30 also contain the results of the various clinical evaluations. Those results are disclosed at paragraph 24 of Dr Traudt’s affidavit;b.to the extent that the format of the report might be said to disclose confidential information about Revlon’s testing processes and methods, that format has been disclosed by exhibit MDT-10;c.there are some differences between the information about Revlon’s testing processes ad methods in the four disputed documents and MDT-10. The degree to which those differences are commercially sensitive is not obvious. The evidence is not that the methodology disclosed in the documents is confidential per se, but rather that the use of the particular methodology for the relevant products at the relevant time is confidential information which is entitled to protection. In the absence of more detailed evidence, and having reviewed the documents, I am unable to determine how the documents could be used by a competitor to the disadvantage of Revlon, and whether any disadvantage might be significant. When considering a claim of confidentiality, it is relevant to consider whether the documents the subject of the claim possess “the necessary quality of confidence” about them, and whether the preservation of the documents’ confidentiality is of substantial concern to the person making the claim: cf Autodata Ltd v Boyce’s Automotive Data Pty Ltd [2007] FCA 1517 at [10]. I can readily accept that the documents contain information about Revlon’s testing processes and methods that are, in fact, kept confidential and may satisfy the tests for confidentiality. It is next necessary to consider whether the documents warrant the protection currently afforded to them by the confidentiality undertakings: cf ICAP Australia Pty Ltd v Moebes [2010] NSWSC 738 at [8] (“ICAP”); Cyclopet Pty Ltd v Australian Nuclear Science and Technology Org [2012] FCA 1326 at [6] (“Cyclopet”)